Burden and characteristics of COVID-19 in the United States during 2020
Columbia University and NIH, Director Francis S. Collins, Nature
https://pubmed.ncbi.nlm.nih.gov/34438440/#affiliation-3
United States, 2020, highest numbers of reported cases and deaths
In the light of later antibody studies
March 11.3%
December, 24.5%
Population susceptibility at year’s end was 69.0%
So, 31% of population had been exposed
(100 million people)
Prevalence rates rose above 0.8% by end of 2020
As high as 2.4% in some major metropolitan areas
Infection fatality rate fell to 0.3% by end of 2020
https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/
As of September 2
5,049,465 children have tested positive
252,000 cases were added the past week
Largest number of child cases in a week ever
Since the pandemic began, children, 15.1% of total cumulated cases
Week ending September 2nd, 26.8% of reported weekly COVID-19 cases
2,400 children were hospitalized nationwide (highest in pandemic)
Hospitalizations (24 states and NYC reported)
Children ranged from 1.6%-4.1% of total cumulated hospitalizations
0.1%-1.9% of all their child COVID-19 cases resulted in hospitalization
Mortality (45 states)
Children were 0.00%-0.27% of all COVID-19 deaths
(7 states reported zero child deaths)
0.00%-0.03% of all child COVID-19 cases resulted in death
Vaccination in children
Half of children ages 12 to 15 have received at least one vaccine dose
58 percent for 16- and 17-year-olds
Anthony Fauci, National Institute of Allergy and Infectious Diseases
We’ve got to get the school system masked,
in addition to surrounding the children with vaccinated people
That’s the solution
Los Angeles mandates today
Soon mandate vaccination for school attendance
600,000 would have to get their first shot by Oct. 3
Second shot by the end of October
(LA counts since last month)
Direct link to vote, https://www.youtube.com/c/Campbellteaching/community
Pascal Soriot, AstraZeneca chief executive on Booster doses
https://www.telegraph.co.uk/business/2021/09/07/covid-booster-jab-campaign-may-not-needed-says-astra-boss/
UK is still “a few weeks away” from being able to decide
Moving too quickly to boost across the entire adult population will deprive us of these insights,
leaving this important decision to rest on limited data
NHS resource implications
Nadhim Zahawi
NHS is ‘ready to go’
Philip Dormitzer, Pfizer’s chief scientific officer
Encouraged booster shots
Dismissed criticism that his company should have produced a more potent vaccine
Professor Sarah Gilbert
Creator of Oxford vaccine Sarah Gilbert warns vulnerable will have to shield as Covid-19 cases rise
UK, 3.8 million people classed as clinically extremely vulnerable
In people who have been vaccinated and have had the two doses,
they will be well protected against disease that is severe enough to put them in hospital and against death
And there are unfortunately some people with particular health conditions that mean they just don’t respond to a vaccine
and they are going to have to make sure that they are protected, probably by shielding again,
if there is a lot of spread of the virus
https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19
we are advising clinically extremely vulnerable people, as a minimum, to follow the same guidance as everyone else
you may wish to think particularly carefully about additional precautions you might wish to continue to take
Sweden
Removing all remaining restrictions by the end of this month
Vietnam
Health Ministry, offering Pfizer-BioNTech as a second-dose after Moderna
(low supplies of the Moderna)
Switzerland
Covid certificates for bars, restaurants, fitness centres starting Monday
(Hospitals busy with wave of infections)
Proof of vaccination, recovery from infection or negative test result
Novavax
Started early-stage study to test combined flu and booster coronavirus vaccine
Along with an adjuvant
Source